Am J Physiol Cell Physiol AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 296: C1364-C1372, 2009. First published April 1, 2009; doi:10.1152/ajpcell.00014.2009
0363-6143/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/6/C1364    most recent
00014.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Zhang, M.
Right arrow Articles by Mei, Y.-A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, M.
Right arrow Articles by Mei, Y.-A.

MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS

Bradykinin inhibits the transient outward K+ current in mouse Schwann cells via the cAMP/PKA pathway

Man Zhang, Xiao-Wei Fei, Yan-Lin He, Guang Yang, and Yan-Ai Mei

Institutes of Brain Science, School of Life Sciences and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China

Submitted 13 January 2009 ; accepted in final form 27 March 2009

Bradykinin (BK) is an endogenous peptide with diverse biological actions and is considered to be an important mediator of the inflammatory response in both the peripheral and the central nervous systems. BK has attracted recent interest as a potential mediator of K+ conductance, Cl channels, and Ca2+-activated K+ channels. However, few reports have associated BK with the voltage-gated K+ current. In this study, we demonstrated that BK suppressed the transient outward potassium current (IA) in mouse Schwann cells using whole cell recording techniques. At a concentration of 0.1 µM to 5 µM, BK reversibly inhibited IA in a dose-dependent manner with the modulation of steady-state activation and inactivation properties. The effect of BK on IA current was abolished after preincubation with a B2 receptor antagonist but could not be eliminated by B1 receptor antagonist. Intracellular application of GTP-{gamma}S induced an irreversible decrease in IA, and the inhibition of Gs using NF449 provoked a gradual augmentation in IA and eliminated the BK-induced effect on IA, while the Gi/o antagonist NF023 did not. The application of forskolin or dibutyryl-cAMP mimicked the inhibitory effect of BK on IA and abolished the BK-induced effect on IA. H-89, an inhibitor of PKA, augmented IA amplitude and completely eliminated the BK-induced inhibitory effect on IA. In contrast, activation of PKC by PMA augmented IA amplitude. A cAMP assay revealed that BK significantly increased intracellular cAMP level. It is therefore concluded that BK inhibits the IA current in Schwann cells by cAMP/PKA-dependent pathways via activation of the B2 receptor.

inactivating A-type outward K+ current; B1/B2 receptor; adenosine 3',5'-cyclic monophosphate/protein kinase A



Address for reprint requests and other correspondence: Y.-A. Mei, School of Life Sciences, Institute of Brain Science, Fudan Univ., Shanghai 200433, P.R. China (e-mail: yamei{at}fudan.edu.cn)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.